On June 29, 2011, the Colombian Congress issued Law 1455, by
means of which it approved the "Madrid Protocol concerning the
Madrid Agreement regarding the international registration of
trademarks", adopted in Madrid, Spain, on June 27, 1989 and
modified on October 3, 2006 and on November 12, 2007.
This Protocol, along with the "Madrid Agreement", is
part of the "Madrid System", which establishes an
international registration scheme for trademarks. The Madrid System
was established on 1891 and is administered by the World
Intellectual Property Organization (WIPO).
At the moment, Law 1455 is being subject to control by the
Constitutional Court that is in charge of analyzing its
constitutionality. Once said Court issues a ruling, Law 1455 should
be deposited before WIPO for ratification.
Once Law 1455 is ratified, Colombia will officially be part of
the Madrid Protocol and, consequently, it will be one of the more
than eighty countries that have ratified this Protocol. Those
interested to obtain the registration of their trademark in several
countries will be able to do it through the International
The Superintendence of Industry and Trade is currently working
on the implementation of the Madrid Protocol through the
institutional strengthening as well as through the adaptation of
the concerning laws, in order to promote and raise the awareness in
the use of this System.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Advocacia Pietro Ariboni Ariboni, Fabbri, Schmidt & Advogados Associados
The current Industrial Property Law, No. 9279/96, has been in
force in Brazil for over a decade. Generally speaking, the Law is
modern and in line with the principles of international treaties
such as TRIPS and the Paris Convention.
In accordance with the Mexican
Patent and Trademark Law in Mexico, in order to maintain patent,
industrial design, and utility model registrations in force through
their life terms, the payment of maintenance fees is necessary.
Current Intellectual Property Law No. 9,279 of May 14, 1996 and the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement allow for patenting of pharmaceuticals in Brazil. Notwithstanding, in 2001, the Brazilian IP Law was amended and the prosecution of pharmaceutical patent applications changed substantially.
Under the Mexican Trademark Law there is no obligation to use a trademark until renewal time is reached in the 10th year as of the filing date of the registration to be renewed and when filing the application for renewal it is only necessary to declare under oath that the mark has been used during a term of the last three years.
In the summer of 1998, Abbot Laboratories was forced to remove from the market a first crystalline form of its medicament ritonavir, a peptidomimetic drug used to treat HIV-1 infection, in favor of a second molecular form, or polymorph, which had different dissolution properties.
In Mexico trademark rights are enforced mainly through the Trademark Office. The enforcement of famous and notorious marks is governed by specific rules
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”